Chip stocks are surging on two distinct macro catalysts: improving Iran-U.S. relations are reducing geopolitical risk premiums across risk assets broadly, and Anthropic's public challenge to U.S. government AI export curbs signals potential loosening of the restrictions that have most directly weighed on NVDA's addressable market. NVDA in particular stands out — revenue of $215.9B grew 65.5% YoY with 71.1% gross margins and 55.6% net margins, a financial profile that needs no narrative tailwind to justify a premium valuation.

The setup hinges on whether either catalyst has durable legs. Iran de-escalation is notoriously fragile, and the Anthropic regulatory battle could take months to resolve. AVGO and QCOM offer exposure with lower beta to the AI-specific narrative, but NVDA remains the primary vehicle if export-restriction relief materializes. Watch for any formal policy signals from the White House or BIS on AI chip rules as the next concrete catalyst.